Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04514237
Ignite Creation Date: 2024-05-06 @ 3:05 PM
Last Modification Date: 2024-10-26 @ 1:42 PM
Study NCT ID: NCT04514237
Protocol Section: NCT04514237
Start Identification Module Data
Expand Identification Module Data
Brief Title: Study to Determine the Relative Bioavailability Single and Repeat Dose Pharmacokinetics Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects
Official Title: A Phase 1 Study to Determine the Relative Bioavailability of BOS172767 Enantiomer E1 and E2 and the Single and Repeat Dose Pharmacokinetics Safety and Tolerability of BOS172767 Selected Enantiomer in Healthy Subjects
Acronym: None
Organization: Boston Pharmaceuticals
Organization Class: INDUSTRY
Organization Study ID: BOS172767-02
Secondary IDs
Secondary ID Type Domain Link
QSC201870 OTHER Quotient Sciences None
2019-002289-11 EUDRACT_NUMBER None None
Start Status Module Data
Status Verified Date: 2020-11
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Boston Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Boston Pharmaceuticals
Start Oversight Module Data 344833
Description Module: 348333
Study Last Update Post Date Type(Status Module):
Attachment: Upload